IMAC Holdings, Inc. Announces Opening Enrollment in Its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’s Disease
05. November 2020 09:00 ET
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn, Nov. 05, 2020 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or “the Company”), a provider of innovative medical advancements and care specializing in regenerative...
Black Friday: Zion Market Research Rains Flat 30 % Discount on All Research Reports
23. November 2017 09:57 ET
|
Zion Market Research
Sarasota, Florida, Nov. 23, 2017 (GLOBE NEWSWIRE) -- Black Friday is here and the world is raining with deals and discounts. So how could we be left behind? We at Zion Market Research are offering...
Veritas Pharma Initiates Cancer Research with Dr. Dmitri Petchkovski
14. November 2017 16:15 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT); (OTC:VRTHF); and (Frankfurt:2VP), (“Veritas” or the “Company”) announces that it has initiated a cancer...